Search Within

Heather Jolie Landau

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (27)
  2. Journal Article (10)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (38)
  2. CTCR Scholars (38)
  3. Center for Hematologic Malignancies (38)
  4. Department of Medicine (38)
  5. Hematologic Malignancies, Division of (38)
  6. MSK Grad Students (38)

More Groups

People
  1. Sergio Giralt (37)
  2. Parastoo Dahi (32)
  3. Gunjan Shah (29)
  4. David Chung (28)
  5. Michael Scordo (24)
  6. Sean Devlin (20)

More People

Years
  1. 2023 (6)
  2. 2022 (3)
  3. 2021 (3)
  4. 2020 (9)
  5. 2019 (7)
  6. 2018 (4)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (14)
  2. Blood (12)
  3. Clinical Lymphoma, Myeloma and Leukemia (4)
  4. Annals of Oncology (1)
  5. Blood Advances (1)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. Elsevier Inc. (19)
  2. American Society of Hematology (13)
  3. American Association for the Advancement of Science (1)
  4. American Society for Clinical Investigation (1)
  5. Cell Press (1)
  6. John Wiley & Sons (1)

More Publishers

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Outpatient BEAM using daily etoposide and cytarabine with autologous hematopoietic stem cell transplantation for lymphoma is feasible and decreases inpatient length of stay
    Meeting Abstract

    Cazeau, N.; Cavalier, K.; Bhatt, V.; McElrath, C.; Lestrange, N.; Lachaud-Richard, M.; Inumerables, F.; Andrejko, M.; Batalha, J.; Cohen, A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Reducing symptom burden in older patients with multiple myeloma (MM) using interleukin-6 (IL-6) blockage peri-autologous hematopoietic stem cell transplantation (AHCT)
    Meeting Abstract

    Shah, G. L.; Kosuri, S.; Holder, J.; Hoover, E.; Chung, D. J.; Dahi, P. B.; Scordo, M.; Landau, H.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Microbiota injury in auto-HCT is frequent, occurs across geography, and is comparable to that observed in allo-HCT
    Meeting Abstract

    Khan, N.; Peled, J. U.; Gomes, A.; Devlin, S. M.; Rondon Clavo, C.; Clurman, A.; Slingerland, J.; Slingerland, A. E.; Maloy, M. A.; Sung, A. D.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Hassoun, H.; Hultcrantz, M.; Korde, N. S.; Lesokhin, A. M.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)
    Meeting Abstract

    Shah, G.; Holder, J.; Cho, S.; Murata, K.; Devlin, S.; Hoover, E.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Loss of microbiota diversity after autologous stem cell transplant is comparable to injury in allogeneic stem cell transplant
    Meeting Abstract

    Khan, N.; Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Rondon-Clavo, C.; Clurman, A.; Slingerland, J. B.; Slingerland, A. E.; Maloy, M.; Sung, A. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Phase 1/2 trial of carfilzomib plus high-dose melphalan preparative regimen for salvage autologous hematopoietic cell transplantation followed by maintenance carfilzomib in patients with relapsed/refractory multiple myeloma
    Journal Article

    Costa, L. J.; Landau, H. J.; Chhabra, S.; Hari, P.; Innis-Shelton, R.; Godby, K. N.; Hamadani, M.; Tamari, R.; Anderton, K.; Dixon, P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save